ABSTRACT Background: The glycemic potential of a diet is associated with chronically elevated insulin concentrations, which may augment breast cancer (BC) risk by stimulating insulin receptor or by affecting insulin-like growth factor I (IGF-I)-mediated mitogenesis. It is unclear whether this effect differs by BC phenotype. Objective: The objective was to investigate the relation between glycemic index (GI), glycemic load (GL), and total carbohydrate intake with BC by using data from the European Prospective Investigation into Cancer and Nutrition (EPIC). Design: We identified 11,576 women with invasive BC among 334,849 EPIC women aged 34-66 y (5th to 95th percentiles) at baseline over a median follow-up of 11.5 y. Dietary GI and GL were calculated from country-specific dietary questionnaires. We used multivariable Cox proportional hazards models to quantify the association between GI, GL, and carbohydrate intake and BC risk. BC tumors were classified by receptor status. Results: Overall GI, GL, and carbohydrates were not related to BC. Among postmenopausal women, GL and carbohydate intake were significantly associated with an increased risk of estrogen receptornegative (ER 2 ) BC when extreme quintiles (Q) were compared [multivariable HR Q5-Q1 (95% CI) = 1.36 (1.02, 1.82; P-trend = 0.010) and HR Q5-Q1 = 1.41 (1.05, 1.89; P-trend = 0.009), 
INTRODUCTION
The glycemic potential of diets high in refined carbohydrates is of interest in the study of breast cancer (BC) 4 etiology on the basis of observations relating insulin resistance in case compared with control subjects (1) . Elevated circulating insulin concentrations may affect BC risk either directly, by stimulating insulin receptors in breast tissue, or indirectly, through the mitogenic effects of insulin-like growth factor I (IGF-I) (2) . Many factors influence how rapidly carbohydrates are digested and absorbed and hence what their glycemic and insulinemic effects will be (3) . This physiologic response of carbohydrates can be quantified by the glycemic index (GI), which compares the plasma glucose response to specific foods with that induced by the same amount of a standard carbohydrate source, usually white bread or pure glucose (4) . The GI is therefore a measure of carbohydrate quality. However, both the quality and quantity of dietary carbohydrates need to be considered in relation to metabolic effects; the glycemic load (GL) of a specific food, calculated as the product of GI and the amount of dietary carbohydrates in a food item, has been proposed as a global indicator of the glucose response and insulin demand induced by a serving of food (5) . Dietary fiber intake could play a role in BC etiology by modulating carbohydrate absorption and mitigating the glycemic response (1) . In addition, dietary fiber intake has been shown to lower circulating concentrations of estrogens and to increase insulin-like growth factor binding protein 3 (IGFBP-3), the main protein carrier for IGF-I (6, 7) .
Several studies have investigated GI and GL as potential risk factors for BC. In a review and meta-analysis that included 6 prospective cohort studies, no clear evidence of increased BC risk was observed with GI and GL among pre-or postmenopausal women (8) , whereas in a very recent meta-analysis that included 4 additional prospective studies, high GI was related to an increased risk of BC in both pre-and postmenopausal women (9) , whereas no association was apparent for GL. However, these reviews did not classify BC by hormone receptor status [estrogen receptor (ER) and progesterone receptor (PR)], which have been shown to affect the clinical, pathologic, and molecular features of tumors and therefore may correspond to etiologically distinct diseases and have disparate risk factor profiles (10, 11) .
Data on the relation between carbohydrates, GI, and GL and hormone receptor-defined BC are scant. Among postmenopausal French women, GL was positively related to ER-negative (ER 2 ) breast tumors (12) , whereas among Danish women, GI was positively related to ER 2 tumor, although GL or other carbohydrates were not associated with BC (13) . Other studies either did not support these results (14) or observed associations with other phenotypes of breast tumor (15) . Inconsistency in the results may be linked in part to a lack of power to evaluate the relation of dietary factors on specific BC phenotypes on the basis of receptor status.
In this article we report results of an analysis conducted on data from 334,849 women followed for 11.5 y, including 11,576 BC cases for which ER status information was known in 63% as well as additional information on PR and human epidermal growth factor receptor 2 (HER2) status. These women are participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
METHODS
The EPIC is a large prospective cohort study conducted in 23 centers in Denmark (Aarhus and Copenhagen), France, Germany (Heidelberg and Potsdam), Greece, Italy (Florence, Varese, Ragusa, Turin, and Naples), Norway, Spain (Asturias, Granada, Murcia, Navarra, and San Sebastian), Sweden (Malmö and Umeå), the Netherlands (Bilthoven and Utrecht), and the United Kingdom (Cambridge and Oxford). Detailed dietary data were collected on cohorts from these countries with large variability in carbohydrate intake. The design and methodology have been published elsewhere (16) .
Eligible men and women were invited to participate; those who accepted provided informed consent and compiled questionnaires on diet, lifestyle, and medical history. EPIC recruited 367,993 women, aged 34-66 y (5th to 95th percentiles). Women with prevalent cancers at any site at recruitment (n = 19,853) or with missing diagnosis or censoring date (n = 2892) were excluded, which left 345,158 women. A total of 3339 subjects with missing dietary or lifestyle information and 6753 women in the top and bottom 1% of the ratio of energy intake to estimated energy requirement (calculated from age, sex, and body weight) were excluded from the analysis. In addition, 217 non-first BC cases were also excluded. Thus, the analysis was performed in 334,849 EPIC women mostly aged 35-70 y with complete exposure information. Within this group, 11,576 women with invasive BC were identified after a median follow-up of 11.5 y. The study was approved by the International Agency for Research on Cancer ethics committee and the local ethics committees of the participating centers.
Dietary assessment and GI/GL calculation
Dietary and lifestyle questionnaires were completed by participants at enrollment when anthropometric measurements were also taken. Diet was assessed by using country-specific food questionnaires designed to capture habitual consumption of food over the preceding year. Eight countries used self-administered food questionnaires, whereas the questionnaires were administered by interviewers in Greece, Spain, and southern Italy (Naples and Ragusa). In most countries, the questionnaires were extensive quantitative instruments that usually contained 260 food items. In Denmark, Norway, Umeå (Sweden), and Naples (Italy), semiquantitative food-frequency questionnaires (FFQs) were administered (16) . Quantitative dietary questionnaires structured by meals were used in Spain, France, and Ragusa (southern Italy). In Malmö (Sweden), a modified diet history method combining a 168-item quantitative food questionnaire (of regularly consumed foods) and a 7-d dietary diary (of cooked lunch and dinner meals) with a 1-h interview was used (16) . In the United Kingdom, an FFQ and a 7-d dietary diary were used, but the present results are from the FFQ. All dietary questionnaires had been previously validated (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . The methods of analyzing the questionnaires and measurements are reported elsewhere (16, 25) . GI values were obtained from the Foster-Powell tables (28) , from British values (29, 30) , from Internet updates (http://www. glycemicindex.com), and from values communicated by GI experts (31, 32) . These values were assigned to individual food items (31, 33) . Food items that contained no or negligible amounts of carbohydrates or that do not increase blood glucose concentrations (chiefly, meat, fish, fats, eggs) were not assigned a value. The dietary GL was calculated by summing, for all foods, the GI value for that food multiplied by the quantity of carbohydrates consumed from that food. Therefore, each unit of GL represents the equivalent blood glucose-increasing effect of 1 g carbohydrates from white bread (or glucose depending on the reference used in determining the GI). The overall GI for each participant was estimated by dividing GL by the total amount of carbohydrates (digestible carbohydrates) consumed. The GI represents the dietary GL per unit of carbohydrates consumed and thus reflects the overall quality of carbohydrate intake in the whole diet (34) .
Anthropometric measurements
Weight and height were measured at baseline, while the subjects were not wearing shoes, to the nearest 0.1 kg or (depending on the center) to the nearest 0.1, 0.5, or 1.0 cm (25, 33) . However, in France, Norway, and Oxford, height and weight were self-reported on a questionnaire. The procedures used to account for procedural differences between centers in the collection of anthropometric measurements are described elsewhere (25, 33) .
Outcome assessment
Incident cancer cases were identified through population cancer registries (Denmark, Italy, Netherlands, Norway, Spain, Sweden, and United Kingdom) or by active follow-up [France, Germany, Naples (Italy), and Greece]. The active follow-up procedure used a combination of methods, including health insurance records, cancer and pathology registries, and contacts with participants and their next of kin. Mortality data were obtained mostly from mortality registries at the regional or national level. Subjects were followed up from study entry and until cancer diagnosis (except for nonmelanoma skin cancer), death, or emigration or until the end of the follow-up period, whichever occurred first. 
Statistical analyses
Lifestyle and dietary baseline characteristics of study participants according to the lowest, middle, and highest quintiles of GI, GL, and carbohydrate intake were determined. Cox proportional hazards regression models were used to quantify the association between GI, GL, and carbohydrates and the risk of BC. Age was the primary time variable, and the Breslow method was adopted for handling ties (35) . Time at entry was age at recruitment; exit time was age at cancer diagnosis, death, loss to follow-up, or end of follow-up, whichever came first. Models were stratified by center to control for differences in questionnaire design, follow-up procedures, and other center effects. Further stratification by age at recruitment (1-y categories) was used. Women were considered as premenopausal when they reported having had regular menses over the previous 12 months or when they were <46 y of age at recruitment. Women were considered as postmenopausal when they reported not having had any menses over the previous 12 mo or when they reported bilateral ovariectomy. Women with missing or incomplete questionnaire data, or with reported previous hysterectomy, were considered postmenopausal only if they were older than 55 y. Women were considered with unknown menopausal status when they were between 46 and 55 y of age, had missing or incomplete questionnaire data, or reported previous hysterectomy (without ovariectomy). Systematic adjustments were undertaken for menopausal status (dichotomized as postmenopausal or women who underwent an ovariectomy compared with other), weight and height (all continuous), smoking (never, former, current), educational attainment (5 categories of schooling) as a proxy variable for socioeconomic status, alcohol intake (continuous), dietary fiber intake (continuous), physical activity (inactive, moderately inactive, moderately active, active). In addition, the following variables were included in the models: age at menarche (,12, 12-14, .14 y), age at birth of first child (nulliparous; ,21, 21-30, .30 y), age at menopause (50, .50 y), ever used contraceptive pills, and ever used replacement hormones. Indicator variables were used to model missing values in
TABLE 1
Lifestyle and dietary baseline characteristics according to the lowest, middle, and highest quintiles of GI and of energy residuals of GL and carbohydrate intake in the EPIC study
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The model was adjusted as in footnote 2 but without adjustment for menopausal status and with the exclusion of women with a history of ovariectomy or unknown menopausal status.
the last 2 variables (a total of 25,882 observations, 876 cases) after checking that the variables associated with these factors were not statistically significant. To model GL and carbohydrate intake, energy adjustment was undertaken with the residual method by using center-specific residual models. Residuals for dietary fiber were also computed and included in the model. For GI, energy, alcohol, and fiber were included in the Cox model in the standard way.
HRs were estimated for quintiles of dietary variables determined on the exposure distribution of the whole cohort, with the first quintile as reference. P values for trends across quintiles were obtained by comparing the Wald test statistics of a score variable with quintile-specific medians to a chi-square distribution with 1 df.
Overall models were fitted, and separate models were used for BMI groups (in kg/m 2 ; 25, .25), dietary fiber-intake groups (,22, 22 g/d), waist circumferences (,78, 78 cm), and waist-hip ratio (,0.78, 0.78). The associations were evaluated according to ER, PR, and HER2 status, as well as for combinations of them. Different models for pre-and postmenopausal subjects were also used, after the exclusion of women with a history of ovariectomy and unknown menopausal status.
Models were fitted with the exclusion of women who developed BC during the first 2 y of follow-up, but the results did not differ from those that included the entire cohort and are not shown. For all dietary exposures, the proportional hazards assumption was satisfied and evaluated via inclusion into the disease model of interaction terms between exposure and attained age (data not shown). Statistical heterogeneity of associations across countries (treating the Oxford health-conscious cohort as a country) was evaluated by comparing the difference in log likelihood of models with and without country-specific interaction terms to chi-square statistics with 10 df. Heterogeneity of associations according to receptor status was performed by using a data augmentation method (36) , by comparing the difference in the log likelihood between a model with receptor status-specific variables and a model with a single HR estimate for the 2 categories of receptor status to a chi-square distribution with 1 df. In all of these models, dietary exposure and, in turn, GI, GL, and carbohydrates were modeled as continuous variables.
Statistical tests were 2-sided, and P values ,0.05 were considered significant. All analyses were performed by using SAS version 9.2 (SAS Institute, 1999).
RESULTS
We documented 11,576 incident BC cases among the 10 countries included in the EPIC study during an average 11.5 y of follow-up (3,670,439 person-years) in 334,849 study participants. Among them, the distribution was as follows: 34.8% were premenopausal and 43.4% were postmenopausal (18.9% of women were not defined and 2.9% reported bilateral ovariectomy). , energy intake (continuous), alcohol intake (continuous), and fiber intake (continuous); GL, carbohydrates, and fiber were modeled by using energy residuals.
3 Derived by using a score variable with quintile-specific medians and comparing the Wald test statistics to a chi-square distribution with 1 df. 4 The model was adjusted as in footnote 2 but without adjustment for menopausal status and with the exclusion of women with a history of ovariectomy or unknown menopausal status.
ER, PR, and HER2 status were available in only 63%, 52%, and 20% of cancer cases, respectively, and were distributed as follows: 80% ER-positive (ER + ) and 20% ER 2 tumors, 64% PR + and 36% PR 2 tumors, and 25% HER2 + and 75% HER2 2 tumors. The mean age at baseline was 50.7 y and was 59.4 y at BC diagnosis. The mean BMI at baseline was 25.0, with a range of 20.2-30.8 (10th and 90th percentiles). The distributions of known risk factors for BC by quintiles of GI, GL, and carbohydrate intake are presented in Table 1 . BMI, height, and use of oral contraceptives or hormone replacement therapy were similar across quintiles of GI, GL, and carbohydrate intake. Participants in the upper quintiles of all exposure variables had a lower intake of alcohol, and those in the upper quintiles of GL and carbohydrate intake had a higher intake of dietary fiber.
The overall median values were equal to 55.8 units for GI, 115.5 units for GL, and 207.2 g/d for carbohydrates. GI, GL, and carbohydrate intake were not associated with overall and pre-or postmenopausal BC ( Table 2) . No interaction was observed with BMI status or other anthropometric measurements (waist-hip ratio and waist circumference). Correlation coefficients adjusted by study center were 0.36 between GI and GL, 0.18 between GI and carbohydrates, and 0.95 between GL and carbohydrates.
In stratified analyses by fiber intake (with the use of EPIC-wide median value of 22 g/d), we observed a significant increased risk with increasing quintile of GI, GL, and carbohydrate intake in women with dietary fiber intake less than the population median. The multivariable adjusted HR comparing the top with the bottom quintile was 1.12 (95% CI: 1.02, 1.24; P-trend = 0.009) for GL among women with low dietary fiber intake (,22 g/d), whereas the equivalent risk estimate was 1.02 (95% CI: 0.93, 1.23; P-trend = 0.98) in women with high dietary fiber intake. This association was particularly apparent among postmenopausal BC cases in whom there was an increased risk estimate for the top compared with the bottom quintile of GI equal to 1.20 (95% CI: 1.05, 1.39; P-trend = 0.004) for women with low fiber intake (,22 g/d; results not shown). However, formal tests of interactions were not significant (P = 0.17 for all women, and P = 0.20 for postmenopausal women in relation to GL).
Cancer cases were classified by their receptor status. We first compared baseline characteristics of cancer cases with and without receptor status information across GI, GL, and carbohydrate categories. We observed no major differences in demographic characteristics and nutritional intake of cases without ER status compared with cases in which information was available. Cancer cases with missing information on PR or HER2 status were more likely to be postmenopausal. No other meaningful difference was noted.
When data were stratified by ER status, borderline significant heterogeneous associations across ER tumors were observed for GL (P = 0.057) and carbohydrates (P = 0.049) but not for GI (P = 0.285). GL and carbohydrate intake were related to ER 2 breast tumors: the HRs comparing the top with the bottom quintile were equal to 1.16 (95% CI: 0.96, 1.41; P-trend = 0.047) for GL and 1.24 (95% CI: 1.02, 1.52; P-trend = 0.013) for carbohydrates ( Table 3) . No significant associations were observed [50 y (ref) , .50 y], energy intake (continuous), alcohol intake (continuous), and fiber intake (continuous); GL, carbohydrates, and fiber were modeled by using energy residuals.
3 Derived by using a score variable with quintile-specific medians and comparing the Wald test statistics to a chi-square distribution with 1 df.
for ER + breast tumors: the HRs comparing the top with the bottom quintile were equal to 1.01 (95% CI: 0.92, 1.11; P-trend = 0.657) for GL and 0.95 (95% CI: 0.86, 1.06; P-trend = 0.292) for carbohydrates (Supplemental Table S1 under "Supplemental data" in the online issue). Further stratification by PR status showed that GL and carbohydrates were also associated with ER 2 /PR 2 tumors: the HRs comparing the top with the bottom quintile were equal to 1.17 (95% CI: 0.94, 1.46; P-trend = 0.11) and 1.33 (95% CI: 1.05, 1.68; P-trend = 0.013), respectively (Table 3) . Among tumor cases with information on ER, PR, and HER2 status, GL and carbohydrate intake were positively related to both triplenegative tumors (ER 2 /PR 2 /HER2 2 ) and ER 2 /PR 2 /HER2 + tumors. These results were based on a small number of cases and did not reach statistical significance ( Table 4) .
The analysis of breast tumor by menopausal status and receptors subgroups showed an increased risk of ER 2 breast tumor among postmenopausal women only ( Table 5) . When the top and bottom quintiles were compared, the HRs were 1.36 (95% CI: 1.02, 1.82; P-trend = 0.012) for GL and 1.41 (95% CI: 1.05, 1.89; P-trend = 0.009) for carbohydrates. The risk of ER 2 /PR 2 BC was only slightly higher than for ER 2 tumors: the HRs comparing the top with the bottom quintile were equal to 1.48 (95% CI: 1.07, 2.05; P-trend = 0.010) and 1.62 (95% CI: 1.15, 2.30; P-trend = 0.005) for GL and carbohydrates, respectively. The small number of cases with triple-negative receptors available among postmenopausal tumors preclude conclusion on the association between GI or GL and BC risk in this subgroup. Among premenopausal women, no increased risk was observed (results not shown).
There was limited evidence of heterogeneity of associations between GI, GL, and carbohydrate intake across countries (Supplemental Figure S1 under "Supplemental data" in the online issue), both overall and by menopausal status.
DISCUSSION
In this prospective study in 334,849 women and 11,576 incident invasive BC cases, there was no overall association of GI, GL, or carbohydrate intake with BC in pre-or postmenopausal women with BC. We observed a positive association between GL and carbohydrates defined as digestible carbohydrates and ER 2 and ER 2 /PR 2 breast tumors among postmenopausal women only but not among premenopausal women and other types of BC jointly defined by ER and PR and HER2 status. No interaction with anthropometric measures was observed. To our knowledge, this is the largest study to date to explore this association with information on receptor status.
GI and GL are measures that evaluate different aspects of total carbohydrate intake. The GL represents the product of GI and the amount of dietary total carbohydrates and is therefore more relevant than the GI (37) . GL and carbohydrate intake are correlated, and recent data provide further evidence of the physiologic validity of GL as a measure of postprandial glycemia and insulin demand (38) . Therefore, if BC is related to the overall insulin demand of the diet, a stronger association would be expected for GL than for GI (15) as was observed in this study. GL has been positively associated with plasma C-peptide, a marker of insulin secretion (39) , and with an increase in [50 y (ref) , .50 y], energy intake (continuous), alcohol intake (continuous), and fiber intake (continuous); GL, carbohydrates, and fiber were modeled by using energy residuals.
inflammatory cytokines (40) . Results from previous studies have been inconsistent with regard to the association of GI and GL with BC risk. Two recent meta-analyses, one that included 6 cohort studies and the other that added 4 more recent cohort studies, reached different conclusions (8, 9) . The positive association observed in the most recent meta-analysis between GI and pre-and postmenopausal BC might be a result of the influence of large recent studies with greater variability in GI and GL. Epidemiologic risk factors have been shown to vary by hormone receptor expression of the breast, supporting the hypothesis that receptor expression represents distinct stable phenotypes for human BC (10, 11, 41) . The lack of expression of certain receptors has been associated with poorer prognosis, such as negative ER and PR status (42) , and HER2, which is overexpressed in 18-20% of BC cases, has been associated with increased recurrence and mortality (43) . Therefore, an analysis of dietary factors should be conducted according to receptor status of breast tumors to support adequate preventive action. This can only be achieved in cohort studies with large numbers of cases.
Our results add further evidence to earlier results from the French component of the EPIC study (included in the current analysis), which reported a positive association between GL and carbohydrate intake and ER 2 BC (12 
/PR
2 BC, although no significant trend was observed (45) . Other studies do not support our results. In the Danish study, a borderline positive association was observed between GI and ER 2 tumors, but results were based on a small number of ER 2 tumors (n = 122) (13) . The Swedish study included a larger number of cases (n = 2952) and an increased risk was observed for ER + /PR 2 BC for both GI and GL. In this study the distribution of receptor status was similar to ours; however, GL values were much higher and showed lower variability compared with our study (15) . The number of cases in the ER 2 /PR 2 category was small (n = 266), and no result was presented on overall ER 2 tumors. In the Australian study (14) the small number of cases (n = 324) precludes strong conclusions regarding the effect of GI and GL on BC defined by specific receptor status.
The biological mechanism for the observed different associations with BC jointly defined by ER and PR status is unclear. A recent pooled analysis found that IGF-I was significantly related to ER + tumors (46) . Our analyses suggest an association with ER 2 tumors, for which a mechanism distinct from the IGF-I pathway might be involved. Insulin could play a direct role by stimulating insulin breast receptors in breast tissue (2) . Alternatively, high-GL diets have been shown to lower adiponectin, an adipocyte-produced insulin sensitizer (47) , which has been associated with a decrease in postmenopausal BC independently of IGF-I-IGFBP-3 concentrations (48, 49) . However, other, nonidentified mechanisms might be involved. Although adiposity is an important determinant of insulin resistance, we did not find an interaction of GI or GL with body fatness in our population, possibly because of the limited percentage (13%) of obese women in our cohorts.
The calculations of dietary GI and GL were performed in a standardized manner across all centers accounting for factors that might influence GI (eg, cooking method, preservation method, and sugar content of country-specific foods) (31); in addition, we used updated information on GI values (32) when relevant. Most of the EPIC dietary consumption data had been collected during 1991-2000; therefore, some of the new data, which reflect the foods available in current markets (eg, new brands), could not be used in the EPIC context. Still, it should be recognized that nutritional questionnaires are subject to measurement errors, and this study is limited by a single dietary assessment. Some participants may have changed their diet during the follow-up, leading to nondifferential misclassification that could have biased the observed association.
Our results also suggest a potential interaction between fiber intake and GL and carbohydrates on the risk of BC as previously reported (50) . This supports the hypothesis of a role of fiber in modifying carbohydrate absorption and in lowering insulin response (51) .
An important concern may be that women with available hormone receptor status may differ from those for whom this was not the case. We observed no differences in demographic characteristics and nutritional intake of cases without ER status compared with cases in which information was available, and subanalyses of this group led to similar overall results. Similar strategies were adopted to inspect BC cases with and without available information on PR and HER2 status. In addition, particularly for HER2 status, the pattern of nonavailable information was distributed rather evenly across EPIC countries. In addition, a bias because of the influence of preclinical disease on diet is unlikely given that results that excluded cases occurring during the first 2 y after baseline provided similar results. However, we conducted a multiple-comparisons analysis on the basis of hormonal status, and chance findings cannot be excluded.
The major strengths of our study include the prospective and population-based design, a large sample size, detailed information on diet, data on hormone receptor status of breast tumors, excellent follow-up, and a large number of cases, which allows greater power for subgroup analyses. However, when considering combinations of hormonal receptor status, small numbers are inevitable, particularly among premenopausal women.
In conclusion, findings from the EPIC cohort suggest that GL and carbohydrate intake are positively associated with ER 2 and ER 2 /PR 2 tumors among postmenopausal women. No interaction with body fatness was observed. Further research is needed to confirm these results and to better understand the mechanisms by which insulinogenic diets might increase the risk of receptornegative breast tumors.
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